Inventor · disambiguated record
Antonio Lanzavecchia
Also filed as: LANZAVECCHIA ANTONIO
66 granted patents·17 pending applications·572 citations·filing 2003–2025
99Inventor score
Files withLANZAVECCHIA ANTONIO18INST RES BIOMEDICINE16INST RESEARCH IN BIOMEDICINE10MEDIMMUNE LLC10INST FOR RES IN BIOMEDICINE9
Top patents by PatentIndex Score
83 records- 0198US8124093B2Human cytomegalovirus neutralizing antibodies and use thereofLANZAVECCHIA ANTONIO·Filed 2009·Granted Feb 28, 2012·41 cites·14 claims
- 0297US8871207B2Neutralizing anti-influenza A virus antibodies and uses thereofLANZAVECCHIA ANTONIO·Filed 2011·Granted Oct 28, 2014·33 cites·11 claims
- 0397US8298539B2Human cytomegalovirus neutralizing antibodies and use thereofLANZAVECCHIA ANTONIO·Filed 2011·Granted Oct 30, 2012·23 cites·14 claims
- 0497US8287870B2Human cytomegalovirus neutralizing antibodies and use thereofLANZAVECCHIA ANTONIO·Filed 2011·Granted Oct 16, 2012·25 cites·16 claims
- 0597US7820166B2Potent T cell modulating moleculesMICROMET AG·Filed 2003·Granted Oct 26, 2010·94 cites·30 claims
- 0696US9249213B2Human cytomegalovirus neutralizing antibodies and use thereofINST RESEARCH IN BIOMEDICINE·Filed 2015·Granted Feb 2, 2016·12 cites·16 claims
- 0796US9127049B2Human cytomegalovirus neutralizing antibodies and use thereofINST RESEARCH IN BIOMEDICINE·Filed 2013·Granted Sep 8, 2015·16 cites·14 claims
- 0896US8435524B2Human cytomegalovirus neutralizing antibodies and use thereofLANZAVECCHIA ANTONIO·Filed 2012·Granted May 7, 2013·16 cites·17 claims
- 0995US11787853B2Neutralizing anti-influenza b antibodies and uses thereofMEDIMMUNE LLC·Filed 2021·Granted Oct 17, 2023·2 cites·26 claims
- 1095US9527902B2Human cytomegalovirus neutralizing antibodies and use thereofINST FOR RES IN BIOMEDICINE·Filed 2016·Granted Dec 27, 2016·9 cites·16 claims
- 1195US9371372B2Human cytomegalovirus neutralizing antibodies and use thereofINST RESEARCH IN BIOMEDICINE·Filed 2015·Granted Jun 21, 2016·10 cites·17 claims
- 1295US9365636B1Human cytomegalovirus neutralizing antibodies and use thereofINST RESEARCH IN BIOMEDICINE·Filed 2015·Granted Jun 14, 2016·10 cites·16 claims
- 1395US8765132B2Human cytomegalovirus neutralizing antibodies and use thereofINST RESEARCH IN BIOMEDICINE·Filed 2013·Granted Jul 1, 2014·14 cites·18 claims
- 1495US8603480B2Human cytomegalovirus neutralizing antibodies and use thereofLANZAVECCHIA ANTONIO·Filed 2009·Granted Dec 10, 2013·14 cites·19 claims
- 1595US8298538B2Human cytomegalovirus neutralising antibodies and use thereofLANZAVECCHIA ANTONIO·Filed 2011·Granted Oct 30, 2012·16 cites·10 claims
- 1695US7947274B2Human cytomegalovirus neutralising antibodies and use thereofHUMABS LLC·Filed 2008·Granted May 24, 2011·30 cites·14 claims
- 1794US9491906B2Human cytomegalovirus neutralizing antibodies and use thereofINST FOR RES IN BIOMEDICINE·Filed 2016·Granted Nov 15, 2016·7 cites·16 claims
- 1894US9221897B2Human cytomegalovirus neutralizing antibodies and use thereofINST RESEARCH IN BIOMEDICINE·Filed 2013·Granted Dec 29, 2015·12 cites·15 claims
- 1994US9217028B2Human cytomegalovirus neutralising antibodies and use thereofLANZAVECCHIA ANTONIO·Filed 2012·Granted Dec 22, 2015·12 cites·13 claims
- 2094US8309089B2Human cytomegalovirus neutralising antibodies and use thereofLANZAVECCHIA ANTONIO·Filed 2011·Granted Nov 13, 2012·20 cites·11 claims
- 2194US8124092B2Antibodies against H5N1 strains of influenza A virusLANZAVECCHIA ANTONIO·Filed 2008·Granted Feb 28, 2012·16 cites·20 claims
- 2294US7955599B2Human cytomegalovirus neutralizing antibodies and use thereofHUMABS LLC·Filed 2008·Granted Jun 7, 2011·29 cites·15 claims
- 2393US11174304B2Neutralizing anti-influenza B antibodies and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Nov 16, 2021·5 cites·22 claims
- 2492US11732011B2Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their useUNIV WASHINGTON·Filed 2021·Granted Aug 22, 2023·2 cites·30 claims
- 2592US10519221B2Neutralizing anti-influenza B antibodies and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Dec 31, 2019·8 cites·21 claims
- 2692US9340603B2Neutralizing anti-influenza A virus antibodies and uses thereofLANZAVECCHIA ANTONIO·Filed 2009·Granted May 17, 2016·13 cites·20 claims
- 2792US9149524B2Human cytomegalovirus neutralising antibodies and use thereofINST RESEARCH IN BIOMEDICINE·Filed 2013·Granted Oct 6, 2015·12 cites·15 claims
- 2892US8685402B2Neutralizing anti-influenza A virus antibodies and uses thereofLANZAVECCHIA ANTONIO·Filed 2009·Granted Apr 1, 2014·12 cites·14 claims
- 2991US9725502B2Human cytomegalovirus neutralizing antibodies and use thereofINST FOR RES IN BIOMEDICINE·Filed 2016·Granted Aug 8, 2017·4 cites·17 claims
- 3090US10420834B2Recombinant metapneumovirus F proteins and their useUS HEALTH·Filed 2015·Granted Sep 24, 2019·4 cites·53 claims
- 3190US9803000B1Human cytomegalovirus neutralizing antibodies and use thereofINST FOR RES IN BIOMEDICINE·Filed 2017·Granted Oct 31, 2017·3 cites·28 claims
- 3289US9796772B2Human cytomegalovirus neutralizing antibodies and use thereofINST FOR RES IN BIOMEDICINE·Filed 2016·Granted Oct 24, 2017·3 cites·24 claims
- 3389US9796771B2Human cytomegalovirus neutralizing antibodies and use thereofINST FOR RES IN BIOMEDICINE·Filed 2016·Granted Oct 24, 2017·3 cites·24 claims
- 3489US9587010B2Neutralizing anti-influenza A virus antibodies and uses thereofLANZAVECCHIA ANTONIO·Filed 2011·Granted Mar 7, 2017·9 cites·17 claims
- 3588US12435113B2Prefusion PIV F immunogens and their useUS HEALTH·Filed 2023·Granted Oct 7, 2025·0 cites·27 claims
- 3688US12233124B2Recombinant metapneumovirus f proteins and their useUS HEALTH·Filed 2023·Granted Feb 25, 2025·0 cites·35 claims
- 3787US12325740B2Neutralizing anti-influenza B antibodies and uses thereofMEDIMMUNE LLC·Filed 2023·Granted Jun 10, 2025·0 cites·16 claims
- 3887US10815294B2Neutralizing anti-influenza A virus antibodies and uses thereofINST RES BIOMEDICINE·Filed 2018·Granted Oct 27, 2020·2 cites·16 claims
- 3987US10494419B2Neutralizing anti-influenza A antibodies and uses thereofMEDIMMUNE LLC·Filed 2014·Granted Dec 3, 2019·9 cites·15 claims
- 4087US10040845B2Human cytomegalovirus neutralizing antibodies and use thereofINST RES BIOMEDICINE·Filed 2017·Granted Aug 7, 2018·2 cites·28 claims
- 4186US12492240B2Neutralizing anti-influenza A antibodies and uses thereofMEDIMMUNE LLC·Filed 2024·Granted Dec 9, 2025·0 cites·16 claims
- 4286US10294292B2Neutralizing anti-influenza B antibodies and uses thereofMEDIMMUNE LLC·Filed 2015·Granted May 21, 2019·4 cites·17 claims
- 4386US9611316B2Human cytomegalovirus neutralising antibodies and use thereofINST FOR RES IN BIOMEDICINE·Filed 2015·Granted Apr 4, 2017·4 cites·16 claims
- 4486US9290786B2Monoclonal antibody production by EBV transformation of B cellsINST RESEARCH IN BIOMEDICINE·Filed 2013·Granted Mar 22, 2016·3 cites·19 claims
- 4584US10414817B2Human cytomegalovirus neutralizing antibodies and use thereofINST RES BIOMEDICINE·Filed 2018·Granted Sep 17, 2019·1 cites·9 claims
- 4684US2025263470A1Neutralizing anti-influenza b antibodies and uses thereofMEDIMMUNE LLC·Filed 2025·Application pending·0 cites
- 4783US10889632B2Human cytomegalovirus neutralizing antibodies and use thereofINST RES BIOMEDICINE·Filed 2019·Granted Jan 12, 2021·0 cites·6 claims
- 4882US12275757B2Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their useUNIV WASHINGTON·Filed 2023·Granted Apr 15, 2025·0 cites·50 claims
- 4981US11078239B2Prefusion PIV F immunogens and their useUS HEALTH·Filed 2017·Granted Aug 3, 2021·1 cites·24 claims
- 5081US8071371B2Monoclonal antibody production by EBV transformation of B cellsLANZAVECCHIA ANTONIO·Filed 2004·Granted Dec 6, 2011·3 cites·30 claims
Showing the top 50 of 83 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Antonio Lanzavecchia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →